DiRocco Derek 4
4 · iTeos Therapeutics, Inc. · Filed Jun 15, 2023
Insider Transaction Report
Form 4
DiRocco Derek
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-13+22,383→ 22,383 totalExercise: $14.77From: 2024-06-13Exp: 2033-06-13→ Common Stock (22,383 underlying)
Footnotes (1)
- [F1]Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the stock option for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund") and the RA Capital Nexus Fund, L.P. (the "Nexus Fund"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon exercise of the stock option, which will offset advisory fees owed by the Fund and the Nexus Fund. The Reporting Person therefore disclaims beneficial ownership of the stock option and underlying Common Stock.